JAK2 and myeloproliferative neoplasm: This report aims to elucidate the clinical presentation, diagnostic workup, and therapeutic strategies for JAK2 V617F-positive latent MPN, emphasizing the critical role of molecular testing and thrombosis prevention in such cases.